Prof. Dr. Oğuzhan Sıtkı DİZDAR

1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

SOLMAZ İ., Kırık A., DEMİR İ., DİZDAR O. S., Gözel N., TAZEGÜL G., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

2. Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study)

Sonmez A., HAYMANA C., Demirci I., Cetinarslan B., GÖNEN M. S., Akbas E. M., et al.

Journal of Diabetes and its Complications , cilt.40, sa.9, 2026 (SCI-Expanded, Scopus)

3. Suboptimal LDL-Cholesterol Control Under the 2019 ESC/EAS Dyslipidemia Guidelines: Results From the Nationwide TEMD-2 Study in Type 2 Diabetes

Caklili O. T., HAYMANA C., Demirci İ., KEBAPÇI M. N., SARIAKÇALI B., EVREN B., et al.

Diabetes, Obesity and Metabolism , cilt.28, sa.9, ss.7779-7790, 2026 (SCI-Expanded, Scopus)

4. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

SÜMBÜL H. E., Kirik A., Yaylaci S., Oral A., Serin S. O., Issever K., et al.

Hepatology International , 2026 (SCI-Expanded, Scopus)

5. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

Kirik A., SÜMBÜL H. E., KOCA N., PAŞALI KİLİT T., Demiral Sezer S., Binnetoglu E., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

6. The Effect of Glucosuria Induced by SGLT2 Inhibitors on Thiamine Levels in Patients with Diabetes Mellitus

Ozcetin M., Bicer I., DİZDAR O. S.

Bratislava Medical Journal , cilt.126, sa.3, ss.309-316, 2025 (SCI-Expanded, Scopus)

7. Effect of SGLT2 inhibitors on thiazolidinedione-induced changes in the volume status of patients with type 2 diabetes mellitus: a 6-month follow-up prospective study

Unlusoy Y. B., DİZDAR O. S., Gunal A. İ.

Archives of Endocrinology and Metabolism , cilt.69, sa.3, 2025 (SCI-Expanded, Scopus)

8. Thiamine status and genes encoding intestinal thiamine transporters and transcription factors in obese subjects

DİZDAR O. S., Erdem S., Deliktas E. D., DOĞAN S., GÜNDOĞAN K., Genton L., et al.

Nutrition, Metabolism and Cardiovascular Diseases , cilt.34, sa.10, ss.2369-2377, 2024 (SCI-Expanded, Scopus)

9. LLL 44-3 Micronutrients in chronic diseases

Lepp H., Amrein K., DİZDAR O. S., Casaer M. P., GÜNDOĞAN K., de Man A. M., et al.

Clinical Nutrition ESPEN , cilt.62, ss.285-295, 2024 (ESCI, Scopus)

10. LLL 44-1 Micronutrients in clinical nutrition: Trace elements

Shenkin A., Talwar D., Ben-Hamouda N., Amrein K., Casaer M. P., de Man A., et al.

Clinical Nutrition ESPEN , cilt.61, ss.369-376, 2024 (ESCI, Scopus)

11. LLL 44 - 2 – Micronutrients in clinical nutrition: Vitamins

Amrein K., de Man A. M., DİZDAR O. S., GÜNDOĞAN K., Casaer M. P., Lepp H., et al.

Clinical Nutrition ESPEN , cilt.61, ss.427-436, 2024 (ESCI, Scopus)

12. LLL 44-4 : Micronutrients in acute disease and critical illness

de Man A. M., Amrein K., Casaer M. P., DİZDAR O. S., van Zanten A. R., GÜNDOĞAN K., et al.

Clinical Nutrition ESPEN , cilt.61, ss.437-446, 2024 (ESCI, Scopus)

13. ESPEN practical short micronutrient guideline

Berger M. M., Shenkin A., DİZDAR O. S., Amrein K., Augsburger M., Biesalski H., et al.

Clinical Nutrition , cilt.43, sa.3, ss.825-857, 2024 (SCI-Expanded, Scopus)

14. Gut microbiota associations with chronic kidney disease: insights into nutritional and inflammatory parameters

Lazarevic V., Teta D., Pruijm M., Stoermann C., Marangon N., Mareschal J., et al.

Frontiers in Microbiology , cilt.15, 2024 (SCI-Expanded, Scopus)

15. Assessment of sestrin 2 as a sepsis marker and predictor of disease severity

Baspınar O., Kocer D., Aydın K., DİZDAR O. S.

Aging Male , cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)

16. Evaluation of whole blood thiamine pyrophosphate concentrations in critically ill patients receiving chronic diuretic therapy prior to admission to Turkish intensive care units: A pragmatic, multicenter, prospective study

GÜNDOĞAN K., Sahin G. G., Ergul S. S., Ozer N. T., TEMEL Ş., Akbas T., et al.

Journal of Critical Care , cilt.77, 2023 (SCI-Expanded, Scopus)

17. Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients

Baspinar O., Kocer D., Kiraz A., Tokmak T. T., DİZDAR O. S.

Medicine (United States) , cilt.102, sa.39, 2023 (SCI-Expanded, Scopus)

18. Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes

Ertugrul D. T., Kan E., Tura C. B., Tugtekin H. B., Ayakta H., Celebioglu M., et al.

International Journal of Diabetes in Developing Countries , cilt.42, sa.1, ss.147-160, 2022 (SCI-Expanded, Scopus)

19. Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus

Elibol A., Eren D., Erdoğan M. D., Elmaağaç M., DİZDAR O. S., ÇELİK İ., et al.

Primary Care Diabetes , cilt.15, sa.5, ss.806-812, 2021 (SCI-Expanded, Scopus)

20. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study)

Sabuncu T., Eren M. A., Çorapçioğlu D., Üçler R., AKIN Ş., HAYMANA C., et al.

Primary Care Diabetes , cilt.15, sa.2, ss.332-339, 2021 (SCI-Expanded, Scopus)

21. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study)

Bayram F., Sonmez A., HAYMANA C., Sabuncu T., DİZDAR O. S., GÜRKAN E., et al.

Lipids in Health and Disease , cilt.19, sa.1, 2020 (SCI-Expanded, Scopus)

22. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study

Tasci I., Demirci I., HAYMANA C., HAYMANA C., BARÇIN C., BARÇIN C., et al.

Diabetes Therapy , cilt.11, sa.5, ss.1045-1059, 2020 (SCI-Expanded, Scopus)

23. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Sonmez A., HAYMANA C., Bayram F., Salman S., DİZDAR O. S., GÜRKAN E., et al.

Diabetes Research and Clinical Practice , cilt.146, ss.138-147, 2018 (SCI-Expanded, Scopus)